Development of T cell-mediated immunity after autologous stem cell transplantation: Prolonged impairment of antigen-stimulated production of γ-interferon

Bone Marrow Transplantation

Volumn 40, Issue 3, 2007, Pages 261-266

  van der Velden, A M T ^a,b   Claessen, A M E ^a   van Velzen Blad, H ^a   Biesma, D H ^a   Rijkers, G T ^a,c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MELPHALAN; MONOCLONAL ANTIBODY CD28; PHYTOHEMAGGLUTININ; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIPHTHERIA; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; POLIOMYELITIS; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STREPTOCOCCUS INFECTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TETANUS; TH1 CELL; VIRUS IMMUNITY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD2; ANTIGENS, CD28; CELL PROLIFERATION; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; INTERFERON TYPE II; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PHYTOHEMAGGLUTININS; STEM CELL TRANSPLANTATION; TETANUS TOXOID; TH1 CELLS; TH2 CELLS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; VIRUS DISEASES;

EID: 34547215828     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705706     Document Type: Article

References (31)

1. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E et al. Treatment of multiple myeloma. Blood 2004; 103: 20-32.
2. Van Imhoff GW, Van der Holt B, MacKenzie MA, Van't Veer MB, Wijermans PW, Ossenkoppele GJ et al. Dutch-Belgian Hemato-Oncology Cooperative Group. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-fine treatment in poor-risk, aggressive non-Hodgkin's lymphoma: Comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40. J Clin Oncol 2005; 23: 3793-3801.
3. Larsson K, Bjorkstrand B, Ljungman P. Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation. Support Care Cancer 1998; 6: 378-383.
4. Molldrem JJ. Vaccinating transplant recipients. Nat Med 2005; 11: 1162-1163.
5. Porrata LF, Litzow MR, Markovic SN. Immune reconstitution after autologous hematopoietic stem cell transplantation. Mayo Clin Proc 2001; 76: 407-412.
6. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471-1490.
7. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60: 672-678.
8. Frere P, Pereira M. Fillet G, Beguin Y. Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. Eur J Haematol 2006; 76: 102-108.
9. Van der Velden AMT, Claessen AM, van Velzen-Blad H, Biesma DH, Rijkers GT. Development of functional haemophilus influenzae type b antibodies after vaccination. Haematologica 2005; 90: 1582-1584.
10. Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM et al. Comparison of multiple immunization schedules for haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 735-741.
11. Nachbaur D, Kropshoger G, Heitger A, Latzer K, Glassl H, Ludescher C et al. Phenotypic and functional lymphocyte recovery after CD34 + -enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res 2000; 9: 727-736.
12. De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10: 133-139.
13. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003; 111: S460-S475.
14. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5: 171-177.
15. De Vries E, de Bruin-Versteeg S, Comans-Bitter WM, de Groot R, Hop WCJ, Boerma GJM et al. Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 2000; 47: 528-537.
16. Avigan D, Wu Z, Joyce R, Elias A. Richardson P, McDermott D et al. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer. Bone Marrow Transplant 2000; 26: 169-176.
17. Akpek G, Lenz G, Lee SM, Sanchorawala. V, Wright DG, Colarusso T et al. Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis. Bone Marrow Transplant 2001; 28: 1105-1109.
18. Te Boekhorst PWA, Lamers CHJ, Schipperus MR, Hintzen RQ, Van der Holt B, Cornelissen JJ et al. T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants. Bone Marrow Transplant 2006; 37: 763-772.
19. Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Leblanc P, Symann ML. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Res 1994; 54: 3800-3807.
20. Singh RK, Varney L, Ino K, Vose JM, Bierman PJ, Talmadge JE. Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients. Exp Hematol 2000; 28: 499-507.
21. Steinke JW, Borish L. Cytokines and chemokines. J Allergy Clin Immunol 2006; 117: S441-S445.
22. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988; 140: 1022-1027.
23. Schlenke P, Sheikhzadeh S, Weber K, Wagner T, Kirchner H. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 251-257.
24. Zeng D, Dejbaksh-Jones S, Srober S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: Impact on blood progenitor cell transplantation. Blood 1997; 90: 453-456.
25. Pan L, Delmonte J, Jalonen C, Ferrara J. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine propduction and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422-4429.
26. Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J et al. Pharmacological doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo Blood 2000; 95: 2269-2274.
27. Han CS, Miller W, Haake R, Weisdorf D.,Varicella zoster infection after bone marrow transplantation: Incidence, risk factors and complications. Bone Marrow Transplant 1994; 13: 277-283.
28. Lee SH, Aggarwal BB, Rinderknecht E, Assisi F, Chiu H. The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin. J Immunol 1984; 133: 1083-1086.
29. Warren MK, Vogel SN. Opposing effects of glucocorticoids on interferon-gamma-induced murine macrophage Fc receptor and Ia antigen expression. J Immunol 1985; 134: 2462-2469.
30. Ljungman P, Engelhard D, de la Cámara R, Einsele H, Locasciulli A, Martino R et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases - Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737-746.
31. Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin R et al. Preventing opportunistic irnfections after hematopoietic stem cell transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice, Guidelines and beyond. Hematology (Am Soo Hematol Educ Program) 2001; 1: 392-421.